OUR SHOW - Noon-2PM will spotlight the opiate epidemic, from community and family impact to law enforcement to Big Pharma. We will also view it from a treatment point of view – specifically with cannabinoid bioscience.

Our Featured Guest is Dr. George E. Anastassov, CEO of AXIM Biotechnologies, Inc. Prior to that Dr. Anastassov was one of the founders and the CEO of CanChew Biotechnologies, LLC. Dr. Anastassov is also one of the founders of Sanammad Foundation and Sanammad Pharmaceuticals; both companies originated and located in The Netherlands. He is one of the developers of the first-in-the-world cannabinoid-containing chewing gum-based delivery system.

Dr. Anastassov possesses Medical and Dental Doctorates as well as an Executive MBA. He has been recognized in “Who’s Who in Medicine” as well as “Who’s Who in Business Professionals” numerous times. He is the recipient of multiple national and international professional and humanitarian awards. Dr. Anastassov has been actively involved in Research and Development in Medicine and Biotechnologies since 1987.
www.aximbiotech.com